Search Results 651-660 of 39159 for Two-phase

1. A Study Of CAD106 And CNP520 Versus Placebo In Participants At Risk For The Onset Of Clinical Symptoms Of Alzheimer's Disease

   Overview. Tab Title Description. Study typeInterventional Study phase2. Study ... The purpose of this study is to test whether two investigational drugs ...

2. A Study of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection - Mayo Clinic

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Sikander Ailawadhi, M.D. - Mayo Clinic Faculty Profiles

   He conducts phase 1 through phase ... 2 inhibitors, monoclonal antibodies and immunomodulatory agents. ... These were investigator-initiated, cooperative group-led ...

4. Oncology (Medical) - Clinical trials

   The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

5. A Dose-Ranging Study to Determine the Effectiveness, Safety and Tolerability of AeroFact - Mayo Clinic

   The purpose of this two-part Phase 2 study is to assess the safety, tolerability and efficacy of aerosolized SF-RI 1 (AeroFact) when delivered via nCPAP at two ...

6. Clinical trials - Oncology (Medical)

   ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti ... The study will be performed in two phases: Phase I will be performed for ...

7. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

8. Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

   Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

10. Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...